# Veno-arterial ExtraCorporeal Membrane Oxygenation to Reduce Morbidity and Mortality Following Lung TransPlant

> **NCT05664204** · NA · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 200 (estimated)

## Conditions studied

- The Number of Ventilator-free Days in the 28 Days Following LT

## Interventions

- **PROCEDURE:** Veno-arterial extracorporeal membrane oxygenation

## Key facts

- **NCT ID:** NCT05664204
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-29
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-09-28
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664204, "Veno-arterial ExtraCorporeal Membrane Oxygenation to Reduce Morbidity and Mortality Following Lung TransPlant". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05664204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
